NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Caplight Logo









Geneus Technologies (Chengdu) Co., Ltd.

Geneus Technologies (Chengdu) Co., Ltd.

Private
ChengduHealthcare & Life Scienceshttp://geneus-tech.com/

Last Round

Series B

Mar 3, 2025

Total Funding Raised

$31.53M

Company Overview

Geneus Technologies (Chengdu) Co., Ltd. is a biotechnology company that develops and commercializes fourth-generation nanopore gene sequencers and related reagents for clinical and research applications.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Biotech Equipment, Precision Medicine

Business Model

B2B

Customer Profile

Hardware Sales, Usage-Based SaaS, Services & Consulting

AI Layer

Application

Keywords

nanopore sequencinggene sequencergenomic sequencinglong-read sequencingnext-gen sequencingNGSbioinformatics softwareclinical diagnosticsprecision medicineMEMSmicroelectromechanical systemssequencing reagentsgenomics tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Geneus Technologies (Chengdu) Co., Ltd. Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Geneus Technologies (Chengdu) Co., Ltd. Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series BMar 3, 2025
Series BMar 2, 2023
Series BSep 29, 2021
Series AJul 31, 2020
AngelJan 29, 2018

Geneus Technologies (Chengdu) Co., Ltd. Investors

Notable investors and investment history

Geneus Technologies (Chengdu) Co., Ltd. Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Geneus Technologies (Chengdu) Co., Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Geneus Technologies (Chengdu) Co., Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersChengdu
Employee Range5
Year Founded2017
Last FundingMar 3, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.